Revenue
2018
2019
2020
2021
2022
2023
2024
2025
ARDELYX, INC. (ARDX)
Price—Loading quote
Net income
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $407.3M | $333.6M | $124.5M | $52.2M | $10.1M | $7.6M | $5.3M | $2.6M | $42.0M | — | $24.0M | $31.6M | $28.9M | $5.4M |
| Gross profit | — | — | — | — | — | — | $4.7M | $2.1M | $33.6M | — | $24.0M | — | — | — |
| Research & development | $71.5M | $52.3M | $35.5M | $35.2M | $91.1M | $65.1M | $71.7M | $69.4M | $75.5M | $94.2M | $39.9M | $25.9M | $28.1M | $10.2M |
| Operating expenses | — | — | — | — | — | — | $95.9M | $93.1M | $98.7M | $112.9M | $53.4M | $33.2M | $31.8M | $14.2M |
| Operating income | −$41.0M | −$27.9M | −$63.3M | −$63.8M | −$154.3M | −$90.8M | −$91.3M | −$90.9M | −$65.1M | −$112.9M | −$29.4M | −$1.6M | −$2.9M | −$8.8M |
| EBITDAderived | −$37.9M | −$25.9M | −$62.0M | −$62.6M | −$151.5M | −$88.2M | −$88.8M | −$88.2M | −$62.5M | −$111.6M | −$28.6M | −$1.3M | −$2.3M | −$8.1M |
| Net income | −$61.6M | −$39.1M | −$66.1M | −$67.2M | −$158.2M | −$94.3M | −$94.9M | −$91.3M | −$64.3M | −$112.4M | −$29.6M | −$3.2M | −$6.6M | −$9.8M |
| Basic EPSper diluted share | -$0.26 | -$0.17 | -$0.30 | -$0.42 | -$1.52 | -$1.05 | -$1.47 | -$1.62 | -$1.36 | -$2.80 | -$1.29 | -$0.31 | -$5.82 | -$11.32 |
| Diluted EPSper diluted share | -$0.26 | -$0.17 | -$0.30 | -$0.42 | -$1.52 | -$1.05 | -$1.47 | -$1.62 | -$1.36 | -$2.80 | -$1.29 | -$0.31 | -$5.82 | -$11.32 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 18, 2026Form 4 · 10b5-1 | Williams Laura AChief Patient Officer | SellCommon Stock | 81.9K | $5.99 | $490.6K | 378.2K |
| Jun 15, 2026Form 4 · 10b5-1 | RAAB MICHAELPresident & CEO | SellCommon Stock | 41.7K | $5.67 | $236.2K | 1.70M |
| May 21, 2026Form 4 | Hohenleitner SusanChief Financial Officer | SellCommon Stock | 1.5K | $6.27 | $9.1K | 229.1K |
| May 21, 2026Form 4 | Brady James ParkerChief Human Resources Officer | SellCommon Stock | 1.8K | $6.27 | $11.6K | 261.1K |
| May 21, 2026Form 4 | Reilly Joseph JamesSee Remarks | SellCommon Stock | 1.0K | $6.27 | $6.5K | 149.8K |